Sally‐Ann Ricketts

Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

Barry R. Davies, Hannah E. Greenwood, Phillippa Dudley et al. · Molecular Cancer Therapeutics · 2012 · 461 citations · Full text

Medicine, Oncology, Pharmacology +16

Micro-CT Imaging of Tumor Angiogenesis

Josef Ehling, Benjamin Theek, Felix Gremse et al. · American Journal Of Pathology · 2013 · 149 citations · Full text

Medicine, Oncology, Radiology +14

A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers

Sean Carlin, Hanwen Zhang, Megan Reese et al. · Journal of Nuclear Medicine · 2014 · 127 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth

Jin Gao, Jon Chesebrough, Susan A. Cartlidge et al. · Cancer Research · 2011 · 120 citations

Medicine, Cancer Biology, Oncology +16

Use of a Novel Arg-Gly-Asp Radioligand,¹⁸F-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy

Matthew Morrison, Sally‐Ann Ricketts, Jon Barnett et al. · Journal of Nuclear Medicine · 2008 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17